The Contract Research Organizations (CROs) Market Report 2022-2032: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Patent Expiry and Increasing Demand for Generic Drugs Projected to Drive Overall CROs Growth
One of the main factors fuelling the demand for generics is the pressure to lower the rising healthcare expenses. The market entry of various less expensive generic substitutes was made possible by patent expiration. Since generic manufacturing firms contract with CDMOs for over 80% of their manufacturing, patent expiration is a positive indication of a booming market. Some of the well-known medications whose patents ran out in 2021 include Lucentis from Roche, Adasuve from Galen, Performist from Mylan, Northera from Lundbeck, and Narcan from Emergent BioSolutions.
Supply Chain Disruptions Likely to Hamper Market
The pharmaceutical sector is susceptible to supply chain disruptions caused by natural disasters in a particular location. High inventory levels alone are insufficient to protect against supply chain shocks since disruptions are becoming more frequent, for instance, the COVID-19 pandemic two years ago and the recent monkeypox outbreak. Anticipatory planning is necessary for managing supply chain interruptions, and several of the large CROs are already highly proficient at foreseeing and resolving shortages. Smaller CROs, however, are more likely to face supply chain disruptions.
The larger CROs have the financial capacity to keep large inventory in case of future financial constraints. The smaller CROs lack the infrastructure and resources necessary to manage supply chains and prevent shortages. Despite difficulties including managing sponsors, workforce scarcity, and market consolidation, the demand for outsourced R&D services will continue to support the CRO business.
What Questions Should You Ask before Buying a Market Research Report?
• How is the Contract Research Organizations (CROs) market evolving?
• What is driving and restraining the Contract Research Organizations (CROs) market?
• How will each Contract Research Organizations (CROs) submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2032?
• How will the market shares for each Contract Research Organizations (CROs) submarket develop from 2022 to 2032?
• What will be the main driver for the overall market from 2022 to 2032?
• Will leading Contract Research Organizations (CROs) markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2032 and which geographical region will lead the market in 2032?
• Who are the leading players and what are their prospects over the forecast period?
• What are the Contract Research Organizations (CROs) projects for these leading companies?
• How will the industry evolve during the period between 2020 and 2032? What are the implications of Contract Research Organizations (CROs) projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the Contract Research Organizations (CROs) market?
• Where is the Contract Research Organizations (CROs) market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the Contract Research Organizations (CROs) market today, and over the next 10 years:
• Our 305-page report provides 116 tables and 180 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the Contract Research Organizations (CROs) market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
Forecasts to 2032 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2032, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising Contract Research Organizations (CROs) prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.
Segments Covered in the Report
Services Outlook
• Preclinical
• Clinical
- Phase I
- Phase II
- Phase III
- Phase IV
• Laboratory Services
• Consulting Services
• Data Management Services
Company Size Outlook
• Large Pharma & Biotech Companies
• Mid-sized Pharma & Biotech Companies
• Small Pharma & Biotech Companies
Drug Type Outlook
• Small Molecules
• Large Molecules
Therapeutic Area Outlook
• Oncology
• CNS
• Cardiology
• Infectious
• Metabolic
• Others
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for four regional and 20 leading national markets:
North America
• U.S.
• Canada
Europe
• Germany
• UK
• France
• Italy
• Spain
• Rest of Europe
Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific
Latin America
• Brazil
• Mexio
• Rest of Latin America
MEA
• GCC
• South Africa
• Rest of MEA
The report also includes profiles and for some of the leading companies in the Contract Research Organizations (CROs) Market, 2022 to 2032, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
• Charles River Laboratories
• Clinipace
• CMIC HOLDING Co., LTD.
• EPS Corporation
• ICON plc
• IQVIA HOLDINGS INC.
• Labcorp Drug Development
• MedPace
• Parexel
• PPD (Thermofisher Scientific Inc.)
• Syneos Health
• Worldwide Clinical Trials
• Wuxi AppTec
Overall world revenue for Contract Research Organizations (CROs) Market, 2022 to 2032 in terms of value the market will surpass US$62 billion in 2022, our work calculates. We predict strong revenue growth through to 2032.
Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the Contract Research Organizations (CROs) Market, 2022 to 2032 report help you?
In summary, our 300+ page report provides you with the following knowledge:
• Revenue forecasts to 2032 for Contract Research Organizations (CROs) Market, 2022 to 2032 Market, with forecasts for services, company size, drug type, and therapeutic area each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
• Revenue forecasts to 2032 for four regional and 13 key national markets – See forecasts for the Contract Research Organizations (CROs) Market, 2022 to 2032 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market – including company profiles for 13 of the major companies involved in the Contract Research Organizations (CROs) Market, 2022 to 2032.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the Contract Research Organizations (CROs) Market, 2022 to 2032, market-leading companies. You will find data, trends and predictions.
'
1. Report Overview
1.1 Objectives of the Study
1.2 Introduction to Contract Research Organizations (CROs) Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered By This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Reports
1.10 About
2 Executive Summary
3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Rising Demand for Clinical Trials Globally
3.2.1.2 Growing Disease Burden Globally to Fuel CROs Market Growth
3.2.1.3 Rising R&D Investments by Pharmaceutical and Biotech Companies to Boost CROs Market Growth
3.2.1.4 Patent Expiry and Increasing Demand for Generic Drugs Projected to Drive Overall CROs Growth
3.2.2 Market Restraining Factors
3.2.2.1 Intellectual Property Issues May Hamper CROs Industry Growth
3.2.2.2 Shortage of Skilled Labour Post COVID-19 Hampering CRO Industry
3.2.3 Market Opportunities
3.2.3.1 Applications of Artificial Intelligence Could Lead to Faster, Safer and Significantly Less Expensive Clinical Trials
3.2.3.2 Increasing Demand for Biological Therapies to Offer Lucrative Growth Prospects for CROs
3.2.3.3 Growth in Nuclear Medicine Sector
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1.1 Competitive Rivalry: High
3.4.1.2 Threat of New Entrants: Low to Medium
3.4.1.3 Threat of Substitutes: Low to Medium
3.4.1.4 Bargaining Power of Buyers: Medium to High
3.4.1.5 Bargaining Power of Suppliers: Medium to High
3.5 PEST Analysis
3.6 How has the Pharmaceutical Industry Adapted Amidst the Pandemic?
3.7 Why are CROs Adopting Mergers & Acquisitions?
3.8 Mergers & Acquisitions Volume and Public Market Valuations
4 Global Contract Research Organizations (CROs) Market Analysis by Services
4.1 Key Findings
4.2 Services Segment Growth Prospects
4.3 Global Contract Research Organizations (CROs) Market Size Estimation and Forecast by Services
4.4 Preclinical
4.4.1 Market Forecast by Region, 2022-2032 (US$ Mn)
4.4.2 Market Share by Region, 2022 & 2032 (%)
4.5 Clinical
4.5.1 Market Forecast by Region, 2022-2032 (US$ Mn)
4.5.2 Market Share by Region, 2022 & 2032 (%)
4.6 Laboratory Services
4.6.1 Market Forecast by Region, 2022-2032 (US$ Mn)
4.6.2 Market Share by Region, 2022 & 2032 (%)
4.7 Consulting Services
4.7.1 Market Forecast by Region, 2022-2032 (US$ Mn)
4.7.2 Market Share by Region, 2022 & 2032 (%)
4.8 Data Management Services
4.8.1 Market Forecast by Region, 2022-2032 (US$ Mn)
4.8.2 Market Share by Region, 2022 & 2032 (%)
5 Global Contract Research Organizations (CROs) Market Analysis by Company Size
5.1 Key Findings
5.2 Company Size Segment Growth Prospects
5.3 Global Contract Research Organizations (CROs) Market Size Estimation and Forecast by Company Size
5.4 Large Pharma & Biotech Companies
5.4.1 Market Forecast by Region, 2022-2032 (US$ Mn)
5.4.2 Market Share by Region, 2022 & 2032 (%)
5.5 Mid-sized Pharma & Biotech Companies
5.5.1 Market Forecast by Region, 2022-2032 (US$ Mn)
5.5.2 Market Share by Region, 2022 & 2032 (%)
5.6 Small Pharma & Biotech Companies
5.6.1 Market Forecast by Region, 2022-2032 (US$ Mn)
5.6.2 Market Share by Region, 2022 & 2032 (%)
6 Global Contract Research Organizations (CROs) Market Analysis by Drug Type
6.1 Key Findings
6.2 Drug Type Segment Growth Prospects
6.3 Global Contract Research Organizations (CROs) Market Size Estimation and Forecast by Drug Type
6.4 Small Molecules
6.4.1 Market Forecast by Region, 2022-2032 (US$ Mn)
6.4.2 Market Share by Region, 2022 & 2032 (%)
6.5 Large Molecules
6.5.1 Market Forecast by Region, 2022-2032 (US$ Mn)
6.5.2 Market Share by Region, 2022 & 2032 (%)
7 Global Contract Research Organizations (CROs) Market Analysis by Therapeutic Area
7.1 Key Findings
7.2 Therapeutic Area Segment Growth Prospects
7.3 Global Contract Research Organizations (CROs) Market Size Estimation and Forecast by Therapeutic Area
7.4 Oncology
7.4.1 Market Forecast by Region, 2022-2032 (US$ Mn)
7.4.2 Market Share by Region, 2022 & 2032 (%)
7.5 CNS
7.5.1 Market Forecast by Region, 2022-2032 (US$ Mn)
7.5.2 Market Share by Region, 2022 & 2032 (%)
7.6 Cardiology
7.6.1 Market Forecast by Region, 2022-2032 (US$ Mn)
7.6.2 Market Share by Region, 2022 & 2032 (%)
7.7 Infectious
7.7.1 Market Forecast by Region, 2022-2032 (US$ Mn)
7.7.2 Market Share by Region, 2022 & 2032 (%)
7.8 Metabolic
7.8.1 Market Forecast by Region, 2022-2032 (US$ Mn)
7.8.2 Market Share by Region, 2022 & 2032 (%)
7.9 Others
7.9.1 Market Forecast by Region, 2022-2032 (US$ Mn)
7.9.2 Market Share by Region, 2022 & 2032 (%)
8 Global Contract Research Organizations (CROs) Market Analysis by Region
8.1 Key Findings
8.2 Regional Market Size Estimation and Forecast
8.3 COVID-19 Impact Analysis: Recovery Scenarios (V, U, W, L)
9 North America Contract Research Organizations (CROs) Market Analysis
9.1 Key Findings
9.2 North America Contract Research Organizations (CROs) Market Attractiveness Index
9.3 Market Size by Country, 2022, 2027 & 2032 (US$ Mn)
9.4 Market Size Estimation and Forecast by Country, 2022-2032 (US$ Mn)
9.5 Market Size Estimation and Forecast by Services, 2022-2032 (US$ Mn)
9.5.1 Market Forecast by Clinical Phase, 2022-2032 (US$ Mn)
9.6 Market Size Estimation and Forecast by Company Size, 2022-2032 (US$ Mn)
9.7 Market Size Estimation and Forecast by Drug Type, 2022-2032 (US$ Mn)
9.8 Market Size Estimation and Forecast by Therapeutic Area, 2022-2032 (US$ Mn)
9.9 U.S. CROs Market Analysis
9.10 Canada CROs Market Analysis
10 Europe Contract Research Organizations (CROs) Market Analysis
10.1 Key Findings
10.2 Europe Contract Research Organizations (CROs) Market Attractiveness Index
10.3 Market Size by Country, 2022, 2027 & 2032 (US$ Mn)
10.4 Market Size Estimation and Forecast by Country, 2022-2032 (US$ Mn)
10.5 Market Size Estimation and Forecast by Services, 2022-2032 (US$ Mn)
10.5.1 Market Forecast by Clinical Phase, 2022-2032 (US$ Mn)
10.6 Market Size Estimation and Forecast by Company Size, 2022-2032 (US$ Mn)
10.7 Market Size Estimation and Forecast by Drug Type, 2022-2032 (US$ Mn)
10.8 Market Size Estimation and Forecast by Therapeutic Area, 2022-2032 (US$ Mn)
10.9 Germany CROs Market Analysis
10.10 UK CROs Market Analysis
10.11 France CROs Market Analysis
10.12 Italy CROs Market Analysis
10.13 Spain CROs Market Analysis
10.14 Rest of Europe CROs Market Analysis
11 Asia Pacific Contract Research Organizations (CROs) Market Analysis
11.1 Key Findings
11.2 Asia Pacific Contract Research Organizations (CROs) Market Attractiveness Index
11.3 Market Size by Country, 2022, 2027 & 2032 (US$ Mn)
11.4 Market Size Estimation and Forecast by Country, 2022-2032 (US$ Mn)
11.5 Market Size Estimation and Forecast by Services, 2022-2032 (US$ Mn)
11.5.1 Market Forecast by Clinical Phase, 2022-2032 (US$ Mn)
11.6 Market Size Estimation and Forecast by Company Size, 2022-2032 (US$ Mn)
11.7 Market Size Estimation and Forecast by Drug Type, 2022-2032 (US$ Mn)
11.8 Market Size Estimation and Forecast by Therapeutic Area, 2022-2032 (US$ Mn)
11.9 Japan CROs Market Analysis
11.10 China CROs Market Analysis
11.11 India CROs Market Analysis
11.12 Australia CROs Market Analysis
11.13 South Korea CROs Market Analysis
11.14 Rest of Asia Pacific CROs Market Analysis
12 Latin America Contract Research Organizations (CROs) Market Analysis
12.1 Key Findings
12.2 Latin America Contract Research Organizations (CROs) Market Attractiveness Index
12.3 Market Size by Country, 2022, 2027 & 2032 (US$ Mn)
12.4 Market Size Estimation and Forecast by Country, 2022-2032 (US$ Mn)
12.5 Market Size Estimation and Forecast by Services, 2022-2032 (US$ Mn)
12.5.1 Market Forecast by Clinical Phase, 2022-2032 (US$ Mn)
12.6 Market Size Estimation and Forecast by Company Size, 2022-2032 (US$ Mn)
12.7 Market Size Estimation and Forecast by Drug Type, 2022-2032 (US$ Mn)
12.8 Market Size Estimation and Forecast by Therapeutic Area, 2022-2032 (US$ Mn)
12.9 Brazil CROs Market Analysis
12.10 Mexico CROs Market Analysis
12.11 Rest of Latin America
13 MEA Contract Research Organizations (CROs) Market Analysis
13.1 Key Findings
13.2 MEA Contract Research Organizations (CROs) Market Attractiveness Index
13.3 Market Size by Country, 2022, 2027 & 2032 (US$ Mn)
13.4 Market Size Estimation and Forecast by Country, 2022-2032 (US$ Mn)
13.5 Market Size Estimation and Forecast by Services, 2022-2032 (US$ Mn)
13.5.1 Market Forecast by Clinical Phase, 2022-2032 (US$ Mn)
13.6 Market Size Estimation and Forecast by Company Size, 2022-2032 (US$ Mn)
13.7 Market Size Estimation and Forecast by Drug Type, 2022-2032 (US$ Mn)
13.8 Market Size Estimation and Forecast by Therapeutic Area, 2022-2032 (US$ Mn)
13.9 GCC CROs Market Analysis
13.10 South Africa CROs Market Analysis
13.11 Rest of MEA CROs Market Analysis
14 Company Profiles
14.1 Competitive Landscape, 2021
14.2 Charles River Laboratories
14.2.1 Company Snapshot
14.2.2 Company Overview
14.2.3 Financial Analysis
14.2.3.1 Net Revenue, 2016-2021
14.2.3.2 Regional Market Shares, 2021
14.2.3.3 Gross Profit, 2016-2021
14.2.4 Product Benchmarking
14.2.5 Strategic Outlook
14.3 Clinipace
14.3.1 Company Snapshot
14.3.2 Company Overview
14.3.3 Product Benchmarking
14.4 CMIC HOLDING Co., LTD.
14.4.1 Company Snapshot
14.4.2 Company Overview
14.4.3 Financial Analysis
14.4.3.1 Net Revenue, 2016-2021
14.4.4 Product Benchmarking
14.4.5 Strategic Outlook
14.5 EPS Corporation
14.5.1 Company Snapshot
14.5.2 Company Overview
14.5.3 Financial Analysis
14.5.3.1 Net Revenue, 2016-2021
14.5.4 Product Benchmarking
14.6 ICON plc
14.6.1 Company Snapshot
14.6.2 Company Overview
14.6.3 Financial Analysis
14.6.3.1 Net Revenue, 2016-2021
14.6.3.2 Gross Profit, 2016-2021
14.6.4 Product Benchmarking
14.6.5 Strategic Outlook
14.7 IQVIA HOLDINGS INC.
14.7.1 Company Snapshot
14.7.2 Company Overview
14.7.3 Financial Analysis
14.7.3.1 Net Revenue, 2016-2021
14.7.3.2 Regional Market Shares, 2021
14.7.3.3 Gross Profit, 2016-2021
14.7.4 Product Benchmarking
14.7.5 Strategic Outlook
14.8 Labcorp Drug Development
14.8.1 Company Snapshot
14.8.2 Company Overview
14.8.3 Financial Analysis
14.8.3.1 Net Revenue, 2016-2021
14.8.3.2 Regional Market Shares, 2021
14.8.3.3 Gross Profit, 2016-2021
14.8.4 Product Benchmarking
14.8.5 Strategic Outlook
14.9 MedPace
14.9.1 Company Snapshot
14.9.2 Company Overview
14.9.3 Financial Analysis
14.9.3.1 Net Revenue, 2016-2021
14.9.3.2 Gross Profit, 2016-2021
14.9.4 Product Benchmarking
14.10 Parexel
14.10.1 Company Snapshot
14.10.2 Company Overview
14.10.3 Product Benchmarking
14.10.4 Strategic Outlook
14.11 PPD (ThermoFisher Scientific Inc.)
14.11.1 Company Snapshot
14.11.2 Company Overview
14.11.3 Financial Analysis
14.11.3.1 Net Revenue, 2016-2021
14.11.3.2 Regional Market Shares, 2021
14.11.3.3 Gross Profit, 2016-2021
14.11.3.4 R&D, 2016-2021
14.11.4 Product Benchmarking
14.11.5 Strategic Outlook
14.12 Syneos Health
14.12.1 Company Snapshot
14.12.2 Company Overview
14.12.3 Financial Analysis
14.12.3.1 Net Revenue, 2016-2021
14.12.3.2 Regional Market Shares, 2021
14.12.3.3 Gross Profit, 2016-2021
14.12.4 Product Benchmarking
14.12.5 Strategic Outlook
14.13 Worldwide Clinical Trials
14.13.1 Company Snapshot
14.13.2 Company Overview
14.13.3 Product Benchmarking
14.13.4 Strategic Outlook
14.14 Wuxi AppTec
14.14.1 Company Snapshot
14.14.2 Company Overview
14.14.3 Financial Analysis
14.14.3.1 Net Revenue, 2016-2021
14.14.3.2 Regional Market Shares, 2021
14.14.3.3 Gross Profit, 2016-2020
14.14.4 Product Benchmarking
14.14.5 Strategic Outlook
15 Conclusion and Recommendations
15.1 Concluding Remarks from
15.2 Recommendations for Market Players
List of Tables
Table 1 Global Contract Research Organizations (CROs) Market Snapshot, 2022 & 2032 (US$ million, CAGR %)
Table 2 Global Contract Research Organizations (CRO) Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 3 Global Contract Research Organizations (CRO) Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 4 Global Contract Research Organizations (CRO) Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 5 Global Contract Research Organizations (CRO) Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 6 Global Contract Research Organizations (CRO) Market Forecast by Service, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 7 Preclinical Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 8 Preclinical Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 9 Laboratory Services Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 10 Consulting Services Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 11 Data Management Services Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 12 Global Contract Research Organizations (CRO) Market Forecast by Company Size, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 13 Large Pharma & Biotech Companies Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 14 Mid-sized Pharma & Biotech Companies Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 15 Small Pharma & Biotech Companies Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 16 Global Contract Research Organizations (CRO) Market Forecast by Drug Type, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 17 Small Molecules Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 18 Large Molecules Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 19 Global Contract Research Organizations (CRO) Market Forecast by Therapeutic Area, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 20 Oncology Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 21 CNS Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 22 Cardiology Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 23 Infectious Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 24 Metabolic Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 25 Others Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 26 Global Contract Research Organizations (CRO) Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 27 Global Contract Research Organizations (CRO) Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 28 Global Contract Research Organizations (CRO) Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 29 Global Contract Research Organizations (CRO) Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 30 Global Contract Research Organizations (CRO) Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 31 North America Contract Research Organizations (CRO) Market Forecast by Country, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 32 North America Contract Research Organizations (CRO) Market Forecast by Service, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 33 North America Contract Research Organizations (CRO) Market Forecast by Clinical Phase, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 34 North America Contract Research Organizations (CRO) Market Forecast by Company Size, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 35 North America Contract Research Organizations (CRO) Market Forecast by Drug Type, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 36 North America Contract Research Organizations (CRO) Market Forecast by Therapeutic Area, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 37 U.S. Contract Research Organizations (CRO) Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 38 Canada Contract Research Organizations (CRO) Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 39 Europe Contract Research Organizations (CRO) Market Forecast by Country, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 40 Europe Contract Research Organizations (CRO) Market Forecast by Service, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 41 Europe Contract Research Organizations (CRO) Market Forecast by Clinical Phase, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 42 Europe Contract Research Organizations (CRO) Market Forecast by Company Size, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 43 Europe Contract Research Organizations (CRO) Market Forecast by Drug Type, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 44 Europe Contract Research Organizations (CRO) Market Forecast by Therapeutic Area, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 45 Germany Contract Research Organizations (CRO) Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 46 UK Contract Research Organizations (CRO) Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 47 France Contract Research Organizations (CRO) Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 48 Italy Contract Research Organizations (CRO) Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 49 Spain Contract Research Organizations (CRO) Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 50 Rest of Europe Contract Research Organizations (CRO) Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 51 Asia Pacific Contract Research Organizations (CRO) Market Forecast by Country, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 52 Asia Pacific Contract Research Organizations (CRO) Market Forecast by Service, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 53 Asia Pacific Contract Research Organizations (CRO) Market Forecast by Clinical Phase, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 54 Asia Pacific Contract Research Organizations (CRO) Market Forecast by Company Size, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 55 Asia Pacific Contract Research Organizations (CRO) Market Forecast by Drug Type, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 56 Asia Pacific Contract Research Organizations (CRO) Market Forecast by Therapeutic Area, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 57 Japan Contract Research Organizations (CRO) Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 58 China Contract Research Organizations (CRO) Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 59 India Contract Research Organizations (CRO) Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 60 Australia Contract Research Organizations (CRO) Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 61 South Korea Contract Research Organizations (CRO) Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 62 Rest of Asia Pacific Contract Research Organizations (CRO) Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 63 Latin America Contract Research Organizations (CRO) Market Forecast by Country, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 64 Latin America Contract Research Organizations (CRO) Market Forecast by Service, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 65 Latin America Contract Research Organizations (CRO) Market Forecast by Clinical Phase, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 66 Latin America Contract Research Organizations (CRO) Market Forecast by Company Size, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 67 Latin America Contract Research Organizations (CRO) Market Forecast by Drug Type, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 68 Latin America Contract Research Organizations (CRO) Market Forecast by Therapeutic Area, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 69 Brazil Contract Research Organizations (CRO) Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 70 Mexico Contract Research Organizations (CRO) Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 71 Rest of Latin America Contract Research Organizations (CRO) Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 72 MEA Contract Research Organizations (CRO) Market Forecast by Country, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 73 MEA Contract Research Organizations (CRO) Market Forecast by Service, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 74 MEA Contract Research Organizations (CRO) Market Forecast by Clinical Phase, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 75 MEA Contract Research Organizations (CRO) Market Forecast by Company Size, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 76 MEA Contract Research Organizations (CRO) Market Forecast by Drug Type, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 77 MEA Contract Research Organizations (CRO) Market Forecast by Therapeutic Area, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 78 GCC Contract Research Organizations (CRO) Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 79 South Africa Contract Research Organizations (CRO) Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 80 Rest of MEA Contract Research Organizations (CRO) Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 81 Charles River Laboratories: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 82 Charles River Laboratories: Product Benchmarking
Table 83 Charles River Laboratories: Strategic Outlook
Table 84 Clinipace: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 85 Clinipace: Product Benchmarking
Table 86 CMIC HOLDING Co., LTD.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 87 CMIC HOLDING Co., LTD.: Product Benchmarking
Table 88 CMIC HOLDING Co., LTD.: Strategic Outlook
Table 89 EPS Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 90 EPS Corporation: Product Benchmarking
Table 91 ICON plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 92 ICON plc: Product Benchmarking
Table 93 ICON plc: Strategic Outlook
Table 94 IQVIA HOLDINGS INC.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 95 IQVIA HOLDINGS INC.: Product Benchmarking
Table 96 IQVIA HOLDINGS INC.: Strategic Outlook
Table 97 Labcorp Drug Development: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 98 Labcorp Drug Development: Product Benchmarking
Table 99 Labcorp Drug Development: Strategic Outlook
Table 100 MedPace: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 101 MedPace: Product Benchmarking
Table 102 Parexel: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 103 Parexel: Product Benchmarking
Table 104 Parexel: Strategic Outlook
Table 105 PPD: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 106 PPD: Product Benchmarking
Table 107 PPD: Strategic Outlook
Table 108 Syneos Health: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 109 Syneos Health: Product Benchmarking
Table 110 Syneos Health: Strategic Outlook
Table 111 Worldwide Clinical Trials: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 112 Worldwide Clinical Trials: Product Benchmarking
Table 113 Worldwide Clinical Trials: Strategic Outlook
Table 114 Wuxi AppTec: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 115 Wuxi AppTec: Product Benchmarking
Table 116 Wuxi AppTec: Strategic Outlook
List of Figures
Figure 1 Global Contract Research Organizations (CROs) Market Segmentation
Figure 2 Global Contract Research Organizations (CROs) Market by Services: Market Attractiveness Index
Figure 3 Global Contract Research Organizations (CROs) Market by Company Size: Market Attractiveness Index
Figure 4 Global Contract Research Organizations (CROs) Market by Drug Type: Market Attractiveness Index
Figure 5 Global Contract Research Organizations (CROs) Market by Therapeutic Area: Market Attractiveness Index
Figure 6 Global Contract Research Organizations (CROs) Market Attractiveness Index by Region
Figure 7 Global Contract Research Organizations (CROs) Market: Market Dynamics
Figure 8 Global Contract Research Organizations (CROs) Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): “V” Shaped Recovery
Figure 9 Global Contract Research Organizations (CROs) Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): “U” Shaped Recovery
Figure 10 Global Contract Research Organizations (CROs) Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): “W” Shaped Recovery
Figure 11 Global Contract Research Organizations (CROs) Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): “L” Shaped Recovery
Figure 12 Porter’s Five Forces Analysis
Figure 13 PEST Analysis
Figure 14 Deal Volume, 2017-2021
Figure 15 Global Contract Research Organizations (CROs) Market Attractiveness Index by Services
Figure 16 Global Contract Research Organizations (CROs) Market Forecast by Services, 2022-2032 (US$ million)
Figure 17 Global Contract Research Organizations (CROs) Market Share Forecast by Services, 2022, 2027, 2032 (%)
Figure 18 Preclinical Market Forecast by Region, 2022-2032 (US$ million)
Figure 19 Preclinical Market Share Forecast by Region, 2022 & 2032 (%)
Figure 20 Clinical Market Forecast by Region, 2022-2032 (US$ million)
Figure 21 Clinical Market Share Forecast by Region, 2022 & 2032 (%)
Figure 22 Laboratory Services Market Forecast by Region, 2022-2032 (US$ million)
Figure 23 Laboratory Services Market Share Forecast by Region, 2022 & 2032 (%)
Figure 24 Consulting Services Market Forecast by Region, 2022-2032 (US$ million)
Figure 25 Consulting Services Market Share Forecast by Region, 2022 & 2032 (%)
Figure 26 Data Management Services Market Forecast by Region, 2022-2032 (US$ million)
Figure 27 Data Management Services Market Share Forecast by Region, 2022 & 2032 (%)
Figure 28 Global Contract Research Organizations (CROs) Market Attractiveness Index by Company Size
Figure 29 Global Contract Research Organizations (CROs) Market Forecast by Company Size, 2022-2032 (US$ million)
Figure 30 Global Contract Research Organizations (CROs) Market Share Forecast by Company Size, 2022, 2027, 2032 (%)
Figure 31 Large Pharma & Biotech Companies Market Forecast by Region, 2022-2032 (US$ million)
Figure 32 Large Pharma & Biotech Companies Market Share Forecast by Region, 2022 & 2032 (%)
Figure 33 Mid-sized Pharma & Biotech Companies Market Forecast by Region, 2022-2032 (US$ million)
Figure 34 Mid-sized Pharma & Biotech Companies Market Share Forecast by Region, 2022 & 2032 (%)
Figure 35 Small Pharma & Biotech Companies Market Forecast by Region, 2022-2032 (US$ million)
Figure 36 Small Pharma & Biotech Companies Market Share Forecast by Region, 2022 & 2032 (%)
Figure 37 Global Contract Research Organizations (CROs) Market Attractiveness Index by Drug Type
Figure 38 Global Contract Research Organizations (CROs) Market Forecast by Drug Type, 2022-2032 (US$ million)
Figure 39 Global Contract Research Organizations (CROs) Market Share Forecast by Drug Type, 2022, 2027, 2032 (%)
Figure 40 Small Molecules Market Forecast by Region, 2022-2032 (US$ million)
Figure 41 Small Molecules Market Share Forecast by Region, 2022 & 2032 (%)
Figure 42 Large Molecules Market Forecast by Region, 2022-2032 (US$ million)
Figure 43 Large Molecules Market Share Forecast by Region, 2022 & 2032 (%)
Figure 44 Global Contract Research Organizations (CROs) Market Attractiveness Index by Therapeutic Area
Figure 45 Global Contract Research Organizations (CROs) Market Forecast by Therapeutic Area, 2022-2032 (US$ million)
Figure 46 Global Contract Research Organizations (CROs) Market Share Forecast by Therapeutic Area, 2022, 2027, 2032 (%)
Figure 47 Oncology Market Forecast by Region, 2022-2032 (US$ million)
Figure 48 Oncology Market Share Forecast by Region, 2022 & 2032 (%)
Figure 49 CNS Market Forecast by Region, 2022-2032 (US$ million)
Figure 50 CNS Market Share Forecast by Region, 2022 & 2032 (%)
Figure 51 Cardiology Market Forecast by Region, 2022-2032 (US$ million)
Figure 52 Cardiology Market Share Forecast by Region, 2022 & 2032 (%)
Figure 53 Infectious Market Forecast by Region, 2022-2032 (US$ million)
Figure 54 Infectious Market Share Forecast by Region, 2022 & 2032 (%)
Figure 55 Metabolic Market Forecast by Region, 2022-2032 (US$ million)
Figure 56 Metabolic Market Share Forecast by Region, 2022 & 2032 (%)
Figure 57 Others Market Forecast by Region, 2022-2032 (US$ million)
Figure 58 Others Market Share Forecast by Region, 2022 & 2032 (%)
Figure 59 Global Contract Research Organizations (CROs) Market Forecast by Region 2022, 2027, 2032 (Revenue, CAGR %)
Figure 60 Global Contract Research Organizations (CROs) Market Share Forecast by Region 2022, 2027, 2032(%)
Figure 61 Global Contract Research Organizations (CROs) Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Figure 62 Global Contract Research Organizations (CROs) Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): “V” Shaped Recovery
Figure 63 Global Contract Research Organizations (CROs) Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): “U” Shaped Recovery
Figure 64 Global Contract Research Organizations (CROs) Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): “W” Shaped Recovery
Figure 65 Global Contract Research Organizations (CROs) Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): “L” Shaped Recovery
Figure 66 North America Contract Research Organizations (CROs) Market Attractiveness Index
Figure 67 North America Contract Research Organizations (CROs) Market by Region, 2022, 2027 & 2032 (US$ million)
Figure 68 North America Contract Research Organizations (CROs) Market Forecast by Country, 2022-2032 (US$ million)
Figure 69 North America Contract Research Organizations (CROs) Market Share Forecast by Country, 2022 & 2032 (%)
Figure 70 North America Contract Research Organizations (CROs) Market Forecast by Services, 2022-2032 (US$ million)
Figure 71 North America Contract Research Organizations (CROs) Market Share Forecast by Services, 2022 & 2032 (%)
Figure 72 North America Contract Research Organizations (CROs) Market Forecast by Company Size, 2022-2032 (US$ million)
Figure 73 North America Contract Research Organizations (CROs) Market Share Forecast by Clinical Phase, 2022 & 2032 (%)
Figure 74 North America Contract Research Organizations (CROs) Market Forecast by Company Size, 2022-2032 (US$ million)
Figure 75 North America Contract Research Organizations (CROs) Market Share Forecast by Company Size, 2022 & 2032 (%)
Figure 76 North America Contract Research Organizations (CROs) Market Forecast by Drug Type, 2022-2032 (US$ million)
Figure 77 North America Contract Research Organizations (CROs) Market Share Forecast by Drug Type, 2022 & 2032 (%)
Figure 78 North America Contract Research Organizations (CROs) Market Forecast by Therapeutic Area, 2022-2032 (US$ million)
Figure 79 North America Contract Research Organizations (CROs) Market Share Forecast by Therapeutic Area, 2022 & 2032 (%)
Figure 80 U.S. Contract Research Organizations (CROs) Market Forecast, 2022-2032 (US$ million)
Figure 81 Canada Contract Research Organizations (CROs) Market Forecast, 2022-2032 (US$ million)
Figure 82 Europe Contract Research Organizations (CROs) Market Attractiveness Index
Figure 83 Europe Contract Research Organizations (CROs) Market by Region, 2022, 2027 & 2032 (US$ million)
Figure 84 Europe Contract Research Organizations (CROs) Market Forecast by Country, 2022-2032 (US$ million)
Figure 85 Europe Contract Research Organizations (CROs) Market Share Forecast by Country, 2022 & 2032 (%)
Figure 86 Eu
